Trial · NCT04649151
Adverse event totals27
The totals the trial posted for each group.
1 to 20 of 27
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Part 1A: mRNA-1273 100 μg | 0 | 2,486 |
| Total, all-cause mortality | Part 1A: Placebo | 0 | 1,240 |
| Total, all-cause mortality | Part 1B: mRNA-1273 100 µg | 0 | 96 |
| Total, all-cause mortality | Part 1C-1: mRNA-1273 50 µg BD | 0 | 1,408 |
| Total, all-cause mortality | Part 1C-2: mRNA-1273 50 μg BD | 0 | 155 |
| Total, all-cause mortality | Part 2: mRNA-1273 50 μg | 0 | 52 |
| Total, all-cause mortality | Part 2: mRNA-1273 50 ug BD | 0 | 19 |
| Total, all-cause mortality | Part 3: mRNA1273.222 50 µg 1 Dose | 0 | 388 |
| Total, all-cause mortality | Part 3: mRNA-1273.222 50 ug Second Dose | 1 | 335 |
| Total, other adverse events | Part 1A: mRNA-1273 100 μg | 943 | 2,486 |
| Total, other adverse events | Part 1A: Placebo | 155 | 1,240 |
| Total, other adverse events | Part 1B: mRNA-1273 100 µg | 22 | 96 |
| Total, other adverse events | Part 1C-1: mRNA-1273 50 µg BD | 429 | 1,408 |
| Total, other adverse events | Part 1C-2: mRNA-1273 50 μg BD | 28 | 155 |
| Total, other adverse events | Part 2: mRNA-1273 50 μg | 12 | 52 |
| Total, other adverse events | Part 2: mRNA-1273 50 ug BD | 7 | 19 |
| Total, other adverse events | Part 3: mRNA1273.222 50 µg 1 Dose | 77 | 388 |
| Total, other adverse events | Part 3: mRNA-1273.222 50 ug Second Dose | 51 | 335 |
| Total, serious adverse events | Part 1A: mRNA-1273 100 μg | 21 | 2,486 |
| Total, serious adverse events | Part 1A: Placebo | 4 | 1,240 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04649151/event-totals